About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Clinical and Translational Radiation Oncology
›
top-articles
Clinical and Translational Radiation Oncology
2.9
(top 20%)
impact factor
777
(top 20%)
papers
6.1K
(top 20%)
citations
32
(top 20%)
h
-index
3.0
(top 20%)
extended IF
783
all documents
6.9K
doc citations
58
(top 20%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
Clinical and Translational Radiation Oncology
2018
415
2
Adaptive radiotherapy: The Elekta Unity MR-linac concept
Clinical and Translational Radiation Oncology
2019
330
3
Technical design and concept of a 0.35 T MR-Linac
Clinical and Translational Radiation Oncology
2019
210
4
COVID-19: Global radiation oncology’s targeted response for pandemic preparedness
Clinical and Translational Radiation Oncology
2020
183
5
Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
Clinical and Translational Radiation Oncology
2018
141
6
Infrastructure and distributed learning methodology for privacy-preserving multi-centric rapid learning health care: euroCAT
Clinical and Translational Radiation Oncology
2017
98
7
Relative biological effectiveness in proton beam therapy – Current knowledge and future challenges
Clinical and Translational Radiation Oncology
2018
96
8
Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
Clinical and Translational Radiation Oncology
2019
86
9
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans
Clinical and Translational Radiation Oncology
2016
81
10
Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review
Clinical and Translational Radiation Oncology
2018
76
11
Spatially fractionated radiation therapy: History, present and the future
Clinical and Translational Radiation Oncology
2020
72
12
4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience
Clinical and Translational Radiation Oncology
2020
71
13
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
Clinical and Translational Radiation Oncology
2018
66
14
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts
Clinical and Translational Radiation Oncology
2020
64
15
Healthcare ex Machina: Are conversational agents ready for prime time in oncology?
Clinical and Translational Radiation Oncology
2019
58
16
The rationale for MR-only treatment planning for external radiotherapy
Clinical and Translational Radiation Oncology
2019
57
17
Daily adaptive radiotherapy for patients with prostate cancer using a high field MR-linac: Initial clinical experiences and assessment of delivered doses compared to a C-arm linac
Clinical and Translational Radiation Oncology
2020
56
18
Learning from scanners: Bias reduction and feature correction in radiomics
Clinical and Translational Radiation Oncology
2019
54
19
Prostate cancer – Advantages and disadvantages of MR-guided RT
Clinical and Translational Radiation Oncology
2019
54
20
PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status
Clinical and Translational Radiation Oncology
2018
51
21
Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment
Clinical and Translational Radiation Oncology
2020
50
22
Radiomic analysis in prediction of Human Papilloma Virus status
Clinical and Translational Radiation Oncology
2017
49
23
MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology
Clinical and Translational Radiation Oncology
2019
48
24
Time to surgery and pathologic complete response after neoadjuvant chemoradiation in rectal cancer: A population study on 2094 patients
Clinical and Translational Radiation Oncology
2017
47
25
Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy
Clinical and Translational Radiation Oncology
2018
47
26
The technical design and concept of a PET/CT linac for biology-guided radiotherapy
Clinical and Translational Radiation Oncology
2021
47
27
Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction
Clinical and Translational Radiation Oncology
2019
46
28
Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma
Clinical and Translational Radiation Oncology
2018
41
29
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial
Clinical and Translational Radiation Oncology
2018
41
30
Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study
Clinical and Translational Radiation Oncology
2019
39
31
A review of the role of MRI in diagnosis and treatment of early stage lung cancer
Clinical and Translational Radiation Oncology
2020
37
32
Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation
Clinical and Translational Radiation Oncology
2018
36
33
Cardiac death after breast radiotherapy and the QUANTEC cardiac guidelines
Clinical and Translational Radiation Oncology
2019
33
34
Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)
Clinical and Translational Radiation Oncology
2018
32
35
Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy
Clinical and Translational Radiation Oncology
2019
32
36
Radiation for ETMR: Literature review and case series of patients treated with proton therapy
Clinical and Translational Radiation Oncology
2019
32
37
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator
Clinical and Translational Radiation Oncology
2021
32
38
Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy
Clinical and Translational Radiation Oncology
2018
31
39
The role of biological dose-escalation for pancreatic cancer
Clinical and Translational Radiation Oncology
2019
31
40
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Clinical and Translational Radiation Oncology
2019
30
41
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance
Clinical and Translational Radiation Oncology
2021
30
42
Organ preservation in rectal cancer – Challenges and future strategies
Clinical and Translational Radiation Oncology
2017
29
43
Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study
Clinical and Translational Radiation Oncology
2017
29
44
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry
Clinical and Translational Radiation Oncology
2022
28
45
Beyond checkpoint inhibition – Immunotherapeutical strategies in combination with radiation
Clinical and Translational Radiation Oncology
2017
27
46
Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report
Clinical and Translational Radiation Oncology
2018
27
47
Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT
Clinical and Translational Radiation Oncology
2018
27
48
Online MR guided radiotherapy for rectal cancer. New opportunities
Clinical and Translational Radiation Oncology
2019
27
49
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine
Clinical and Translational Radiation Oncology
2020
27
50
Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey
Clinical and Translational Radiation Oncology
2018
26
site/software ©
exaly
; All materials licenced under
CC by-SA
.